Literature DB >> 2448555

High expression of ets-1 gene in human thymocytes and immature T leukemic cells.

N Sacchi1, A de Klein, S D Showalter, G Bigi, T S Papas.   

Abstract

The cellular ets-1 gene homologous to the 5' region of the v-ets sequence of the E26 retrovirus codes for a 6.8-kb mRNA that is translated into a 51-kDa protein in human cells. A survey of mRNA from human tissues showed the thymus as the tissue with the highest level of ets-1 transcription, within other hematopoietic organs and tissues, including spleen, fetal liver, lymph nodes, bone marrow, and peripheral lymphocytes exhibiting low or undetectable levels of hybridization. A high level of ets-1 expression was found in murine thymocyte mRNA as well. Investigation of the ets-1 expression levels in human leukemic samples showed that primary malignant T cells (T-ALLs), corresponding to intrathymic stages of maturation, have a much higher level of ets-1 mRNA than malignant T lymphoid cells with a mature phenotype, such as adult T cell leukemias (ATLs). T-ALLs were also higher in ets-1 expression than the other lymphoid (pre-T-ALL, c-ALL, pre-B-ALL) malignant cells analyzed. Insignificant amounts of the specific ets-1 mRNA were detected in several acute myeloid leukemias representing various degrees of maturation. The elevated ets-1 mRNA in thymocytes suggests a biological role for the ets-1 product in these cells that could be explored to investigate ets-1 function. Finally, the exhibited expression of ets-1 in lymphoid cells and absence from malignant myeloid cells makes it a candidate marker for phenotyping human hematopoietic tumors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2448555

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  14 in total

1.  Sequence-specific interaction of the Ets1 protein with the long terminal repeat of the human T-lymphotropic virus type I.

Authors:  S D Gitlin; R Bosselut; A Gégonne; J Ghysdael; J N Brady
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

2.  Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene ETS1.

Authors:  N K Bhat; C B Thompson; T Lindsten; C H June; S Fujiwara; S Koizumi; R J Fisher; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

3.  The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Authors:  Lee Ann Garrett-Sinha; Alyssa Kearly; Anne B Satterthwaite
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

4.  Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene.

Authors:  G J Mavrothalassitis; D K Watson; T S Papas
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

5.  ets-1 in astrocytes: expression and transmitter-evoked phosphorylation.

Authors:  L F Fleischman; L Holtzclaw; J T Russell; G Mavrothalassitis; R J Fisher
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

6.  Transcriptional activation of the human T-lymphotropic virus type I long terminal repeat by functional interaction of Tax1 and Ets1.

Authors:  S D Gitlin; J Dittmer; R C Shin; J N Brady
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

7.  Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter.

Authors:  M A Majérus; F Bibollet-Ruche; J B Telliez; B Wasylyk; B Bailleul
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

Review 8.  Review of Ets1 structure, function, and roles in immunity.

Authors:  Lee Ann Garrett-Sinha
Journal:  Cell Mol Life Sci       Date:  2013-01-05       Impact factor: 9.261

9.  Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1.

Authors:  J Dittmer; S D Gitlin; R L Reid; J N Brady
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

10.  Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages.

Authors:  Carmen G Palii; Carolina Perez-Iratxeta; Zizhen Yao; Yi Cao; Fengtao Dai; Jerry Davison; Harold Atkins; David Allan; F Jeffrey Dilworth; Robert Gentleman; Stephen J Tapscott; Marjorie Brand
Journal:  EMBO J       Date:  2010-12-21       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.